CKD患者与肾移植受者的睡眠相关障碍
综述阐述CKD、透析及肾移植受者中失眠、不宁腿综合征和睡眠呼吸暂停的患病率、危险因素、不良结局及治疗选择。这些睡眠障碍随肾功能恶化而更常见且更严重,并与CKD进展、发病和死亡风险增加相关。
要点
- CKD患者失眠、RLS和SA患病率高于一般人群。
- 透析患者睡眠障碍患病率最高,肾移植受者相对较低。
- 睡眠障碍与CKD进展、发病率和死亡率增加相关。
核心结论
- 失眠、不宁腿综合征和睡眠呼吸暂停在CKD患者中常见,随肾功能恶化至ESKD而更普遍且更严重。
- 这些睡眠障碍和疲劳与CKD进展、发病风险、死亡风险增加及健康相关生活质量降低相关。
研究设计与样本
- 综述,讨论失眠、RLS和SA及疲劳的诊断评估、流行病学、危险因素与关联、结局、治疗和移植后结局。
主要发现
- 一般人群失眠患病率为4%-29%,CKD患者30%-67%,血液透析患者39%-54%,腹膜透析患者41%-79%,肾移植受者9%-49%。
- 一般人群RLS患病率约1%-15%,CKD患者5%-18%,血液透析患者24%-33%,腹膜透析患者23%-64%,肾移植受者6%-8%。
- 阻塞性睡眠呼吸暂停在CKD患者报告为40%-69%,血液透析患者25%-47%,腹膜透析患者9%-52%,肾移植受者25%-30%。
- 疲劳在CKD、ESKD和肾移植受者中均有报告,可与睡眠障碍相关。
临床怎么用
- 综述强调非药物和药物选项用于治疗失眠、RLS和SA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sleep disorders such as insomnia, restless legs syndrome (RLS), and sleep apnea (SA) are common in patients with CKD. These conditions tend to become more prevalent and more severe as kidney function deteriorates and when a patient reaches ESKD. The prevalence of insomnia in the general population ranges from 4% to 29% compared with ( 1 ) 30%-67%, ( 2 ) 39%-54%, ( 3 ) 41%-79%, and ( 4 ) 9%-49% in patients with CKD, on hemodialysis, on peritoneal dialysis (PD), or in kidney transplant recipients (KTRs), respectively. RLS occurs in approximately 1%-15% of the general population compared with ( 1 ) 5%-18%, ( 2 ) 24%-33%, ( 3 ) 23%-64%, and ( 4 ) 6%-8% in patients with CKD, on hemodialysis, on PD, or in KTRs, respectively. Obstructive SA has been reported in ( 1 ) 40%-69%, ( 2 ) 25%-47%, ( 3 ) 9%-52%, and ( 4 ) 25%-30% in patients with CKD, on hemodialysis, on PD, or in KTRs, respectively. Fatigue is a complex symptom that has been reported in patients with CKD, ESKD, and in KTRs and can be associated with sleep disorders. Fatigue and sleep disorders have been associated with negative outcomes such as progression of CKD, increased risk of morbidity, mortality, and lower health-related quality of life. In this review, we highlight nonpharmacologic and pharmacologic options for treatment of these sleep disorders. Specifically, the diagnosis and evaluation, epidemiology, risk factors and associations, outcomes (such as CKD progression, morbidity, and mortality), treatment, and post-transplant outcomes for sleep disorders (insomnia, RLS, and SA) and fatigue will be discussed.
引用
- Vendeville N, Mucsi I, Molnar MZ, et al. Sleep-Related Disorders in Patients with CKD and Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2025. PMID: 40202805. doi:10.2215/CJN.0000000728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。